<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhuang J</submitter><funding>Shaanxi Youth Rising Stars in Science and Technology</funding><funding>Key Research and Development Program of Shaanxi Province</funding><funding>Shaanxi Province Key Industry Innovation Chain Project</funding><funding>National Natural Science Foundation of China</funding><funding>Innovation Capability Support Program of Shaanxi</funding><funding>Shenzhen Science and Technology Program</funding><pagination>0663</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11959697</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>Sepsis, a life-threatening inflammatory disorder characterized by multiorgan failure, arises from a dysregulated immune response to infection. Modulating macrophage polarization has emerged as a promising strategy to control sepsis-associated inflammation. The endogenous metabolite itaconate has shown anti-inflammatory potential by suppressing the stimulator of interferon genes (STING) pathway, but its efficacy is inhibited by hyperactive glycolysis, which sustains macrophage overactivation. Here, we revealed a critical crosstalk between the itaconate-STING axis and glycolysis in macrophage-mediated inflammation. Building on this interplay, we developed a novel nanoparticle LDO (lonidamine disulfide 4-octyl-itaconate), a self-assembled metabolic regulator integrating an itaconate derivativ</pubmed_abstract><journal>Research (Washington, D.C.)</journal><pubmed_title>A Self-Assembled Metabolic Regulator Reprograms Macrophages to Combat Cytokine Storm and Boost Sepsis Immunotherapy.</pubmed_title><pmcid>PMC11959697</pmcid><funding_grant_id>2023-ZDLSF-59</funding_grant_id><funding_grant_id>2022SF-374</funding_grant_id><funding_grant_id>JCYJ20240813150807010</funding_grant_id><funding_grant_id>82173682</funding_grant_id><funding_grant_id>2021KJXX-92</funding_grant_id><funding_grant_id>2024ZC-KJXX-119</funding_grant_id><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Lu X</pubmed_authors><pubmed_authors>Sun B</pubmed_authors><pubmed_authors>Hai Y</pubmed_authors><pubmed_authors>Fan R</pubmed_authors><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Han B</pubmed_authors><pubmed_authors>Luo L</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Wei G</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Zhuang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Self-Assembled Metabolic Regulator Reprograms Macrophages to Combat Cytokine Storm and Boost Sepsis Immunotherapy.</name><description>Sepsis, a life-threatening inflammatory disorder characterized by multiorgan failure, arises from a dysregulated immune response to infection. Modulating macrophage polarization has emerged as a promising strategy to control sepsis-associated inflammation. The endogenous metabolite itaconate has shown anti-inflammatory potential by suppressing the stimulator of interferon genes (STING) pathway, but its efficacy is inhibited by hyperactive glycolysis, which sustains macrophage overactivation. Here, we revealed a critical crosstalk between the itaconate-STING axis and glycolysis in macrophage-mediated inflammation. Building on this interplay, we developed a novel nanoparticle LDO (lonidamine disulfide 4-octyl-itaconate), a self-assembled metabolic regulator integrating an itaconate derivativ</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-04-08T19:47:18.284Z</modification><creation>2026-04-08T14:29:05.649Z</creation></dates><accession>S-EPMC11959697</accession><cross_references><pubmed>40171016</pubmed><doi>10.34133/research.0663</doi></cross_references></HashMap>